PATENT CLAIM ANALYSIS

Application Number: 15771476
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "415000"]

Abstract:
The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.

Claim (Index 6):
The method of  claim 1 , wherein R 2  is NHC(O)\u2014CH\u2550CH\u2014C(O)R b  or NHC(O)\u2014CH\u2550CH\u2014C(O)NR c R d ; and R 3 , R 5 , and R 6  is independently CH\u2550CH\u2014C(O)NR c R d , NHC(O)\u2014CH\u2550CH\u2014C(O)R b , or NHC(O)\u2014CH\u2550CH\u2014C(O)NR c R d .

Metadata:
- Claim Count in Document: 31.0
- Percentile: 91.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15852977', '11238285', '15737125', '14448998', '14772334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7018017374881157
- 35 USC 102 Novelty (BERT): 0.5068699796634514
- Combined Prediction Score: 0.6823085617056492
- Mean Citation Score: 210.18250200000003
- Max Citation Score: 220.74232
- Similarity Product: 147.5310729121399

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test